Ravinder Verma
Overview
Explore the profile of Ravinder Verma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verma R, Bhatia M, Mojumder M, Patel S, Mishra V, Mathur P, et al.
Pharm Nanotechnol
. 2024 Sep;
PMID: 39328131
The potential use of nanoparticle-based formulations is being explored rapidly for drug delivery in ocular treatment. Despite having several advancements in the area of ocular therapy, the pharmacokinetics-based formulation development...
2.
Wadhwa K, Chauhan P, Kumar S, Pahwa R, Verma R, Goyal R, et al.
Oncol Res
. 2024 Apr;
32(5):877-897.
PMID: 38686045
Background: Glioblastoma multiforme (GBM) is recognized as the most lethal and most highly invasive tumor. The high likelihood of treatment failure arises from the presence of the blood-brain barrier (BBB)...
3.
Rani L, Mathur P, Verma R, Kumar V, Mishra A, Sahoo P
Curr Rheumatol Rev
. 2024 Apr;
PMID: 38629371
Rheumatoid arthritis is a systemic autoimmune disorder related to joint inflammation, bone erosion, and deformity. Numerous studies indicate that the causes and consequences of RA are still being debated, and...
4.
Singla R, Singh D, Verma R, Kaushik D, Echeverria J, Garg V, et al.
Phytomedicine
. 2024 Jan;
124:155286.
PMID: 38241906
Background: Fermented formulations are extensively used in Ayurveda due to several benefits like improved palatability, bioavailability, pharmacological potential, and shelf life. These formulations can also quench the heavy metals from...
5.
Mathur P, Verma R, Rani L, Kamboj S, Kamboj R, Kamboj T, et al.
Recent Pat Nanotechnol
. 2023 Nov;
PMID: 38018214
Poloxamers, commonly known as Pluronics, are a special family of synthetic tri-block copolymers with a core structure made of hydrophobic poly (propylene oxide) chains sandwiched by two hydrophilic poly (ethylene...
6.
Verma R, Rao L, Kumar H, Bansal N, Deep A, Parashar J, et al.
Recent Pat Nanotechnol
. 2023 Nov;
19(1):99-119.
PMID: 37937554
Background: The most difficult kind of cancer to treat is brain cancer, which causes around 3% of all cancer-related deaths. The targeted delivery is improved with the use of technologies...
7.
Verma R, Rao L, Nagpal D, Yadav M, Kumar M, Mittal V, et al.
Recent Pat Nanotechnol
. 2023 Oct;
18(3):278-294.
PMID: 37904561
Cancer is a complex, one of the fatal non-communicable diseases, and its treatment has enormous challenges, with variable efficacy of traditional anti-cancer agents. By 2025, it is expected that 420...
8.
Mathur P, Bhatt S, Kumar S, Kamboj S, Kamboj R, Rana A, et al.
Curr Drug Deliv
. 2023 Oct;
21(9):1180-1196.
PMID: 37818568
The majority of deadly cancers that afflict the female reproductive system occur in the ovary. Around 1,40,000 women worldwide die from ovarian cancer each year, making it the sixth most...
9.
Dhir S, Bhatt S, Chauhan M, Garg V, Dutt R, Verma R
Recent Pat Nanotechnol
. 2023 Sep;
18(4):415-432.
PMID: 37680162
Background: Nanotechnology has gained enormous attention in pharmaceutical research. Nanotechnology is used in the development of nanoparticles with sizes ranging from 1-100 nm, with several extraordinary features. Metallic nanoparticles (MNPs)...
10.
Sharma J, Bhatt S, Tiwari A, Tiwari V, Kumar M, Verma R, et al.
Saudi Pharm J
. 2023 Aug;
31(9):101727.
PMID: 37638219
In the past, curcumin was the go-to medication for diabetes, but recent studies have shown that tetrahydrocurcumin is more effective. The problem is that it's not very soluble in water...